Chemokines mediate diverse functions from organogenesis to mobilizing leucocytes, and are unusual agonists for class-A GPCRs (G-protein-coupled receptors) because of their large size and multi-domain structure. The current model for receptor activation, which involves interactions between chemokine N-loop and receptor N-terminal residues (Site-I) and between chemokine N-terminal and receptor extracellular loop/transmembrane residues (Site-II), fails to describe differences in ligand/receptor selectivity and the activation of multiple signalling pathways. In the present study, we show in neutrophil-activating chemokine CXCL8 that the highly conserved GP (glycine-proline) motif located distal to both N-terminal and N-loop residues couples Site-I and Site-II interactions. GP mutants showed large differences from nativelike to complete loss of function that could not be correlated with the specific mutation, receptor affinity or subtype, or a specific signalling pathway. NMR studies indicated that the GP motif does not influence Site-I interactions, but molecular dynamics simulations suggested that this motif dictates substates of the CXCL8 conformational ensemble. We conclude that the GP motif enables diverse receptor functions by controlling cross-talk between Site-I and Site-II, and further propose that the repertoire of chemokine functions is best described by a conformational ensemble model in which a network of long-range coupled indirect interactions mediate receptor activity.
INTRODUCTION
Chemokines, a large family of ∼8-10 kDa proteins, play fundamental roles from developmental biology to trafficking immune cells and combating infection by activating receptors that belong to the GPCR (G-protein-coupled receptor) class [1] . They show a wide repertoire of receptor functions, as a given chemokine can bind single or multiple receptor(s), and binding to any one receptor can elicit multiple signalling pathways and different activities [1, 2] . According to the prevalent model, chemokine receptor activation involves interactions between chemokine Nloop and receptor N-terminal residues (Site-I), and between chemokine N-terminal and receptor extracellular/transmembrane residues (Site-II) [2] [3] [4] [5] [6] . This model, although appealing in its simplicity, fails to describe the large variation in receptor selectivity, affinity and activity for a given chemokine and among chemokines.
Sequence analysis of neutrophil-activating chemokines in humans and across other species show that the GP (glycineproline) residues which form a β-turn in the 30s-loop are highly conserved ( Figure 1A ). Structures reveal that the 30s-loop is located distal to both the N-terminal and N-loop regions ( Figure 1B ). High conservation implies that it must play some crucial role for structure and/or function. Therefore the GP motif could be essential for the structural fold and/or for receptor activity by directly binding receptors or indirectly influencing how Nterminal/N-loop residues bind and activate the receptors.
Chemokine CXCL8 [also known as IL-8 (interleukin-8)] recruits neutrophils by activating the CXCR1 and CXCR2 receptors. Structure-function studies have shown that the Nterminal ELR and N-loop residues play important roles in defining affinity and receptor activity [5, 7, 8] . Chemokine PF-4/CXCL4 has the GP motif and is not active for CXCR1/CXCR2 receptors, but becomes active on introducing the N-terminal ELR motif [9] . The chemokine IP-10/CXCL10 does not have the GP motif and is not active against CXCR1/CXCR2 receptors [10] . However, a CXCL10/CXCL8 chimaera containing the 30s-loop, N-terminal ELR and N-loop residues of CXCL8 is active, but a chimaera containing the 30s-loop and ELR residues is not active [7] . Therefore the mere presence of 30s-loop GP motif or even the additional presence of ELR residues are not sufficient for CXCL8 activity, indicating that receptor activation is finely tuned and requires optimal cross-talk among N-terminal, N-loop and 30s-loop residues.
To address the role of the GP motif in CXCL8 function, we have now characterized the structural and functional properties of a panel of GP mutants (G31A, G31V, P32G and P32A). The mutants show large differences in activity that could not be correlated with the nature of the mutation, receptor type and/or a specific signalling pathway. NMR studies show that the mutations do not perturb the global fold, any local structural change could
Figure 1 Structural characteristics of CXCL8
(A) Sequence alignment of human CXCL8 (hCXCL8) and related neutrophil-activating chemokines, and CXCL8 from other species. N-terminal ELR residues (in green) are absolutely conserved and the 30s-loop 'GP' motif (in red) is highly conserved, except in CXCL7. The N-loop residues are indicated by a blue bar. (B) Tertiary structural components of the CXCL8 monomer. The 30s-loop, N-loop (Site-I), ELR residues (Site-II) and disulfide bonds (black) are highlighted. The GP motif in the β-turn of the 30s-loop are shown as sticks, and the hydrogen bonds between Gly 31 and Cys 34 are shown as broken lines (see insert).
not be correlated with functional changes, and that they bind the receptor N-domain like WT (wild-type) indicating that the GP motif does not participate or influence Site-I interactions. MD (molecular dynamics) simulations show that perturbing the GP motif leads to conformational rearrangement and altered dynamics resulting in access to non-native conformations, thus providing a rationale for the stringent requirement of the GP motif for native function. We propose that the GP motif functions as a conformational switch and dictates the distribution and selection of the functionally competent conformational substates that activate various signalling pathways. We further propose that the 'conformational selection' model can best describe the spectrum of chemokine receptor functions [11, 12] .
MATERIALS AND METHODS

Cloning, expression and purification of CXCL8 GP mutants
The 30s-loop G31A, G31V, P32G and P32A mutants were generated using the QuikChange ® Site-Directed Mutagenesis kit (Stratagene). Two versions of the mutant proteins, the full length (residues 1-72) and a truncated monomeric form (residues 1-66) were generated. The CXCL8-(1-66) deletion mutant is a monomer, and its receptor affinity and activity are similar to those of the trapped full-length monomer [8, 13, 14] . Both versions of the mutants were expressed and purified as described previously [13, 15] . 15 N-labelled monomer mutants for NMR studies were produced essentially as described previously, except that cells were grown in minimal medium containing 15 NH 4 Cl as the sole nitrogen source [15] . The purity and molecular mass of the mutants were confirmed using analytical HPLC and MALDI-MS.
Radioligand receptor-binding assays
Radioligand-binding assays were carried out using CXCR1-and CXCR2-transfected RBL-2H3 cells as described previously [16] . Briefly, RBL-2H3 cells sub-cultured overnight in 24-well plates (0.5×10 6 cells) in growth medium were rinsed with DMEM (Dulbecco's modified Eagle's medium) supplemented with 20 mM Hepes (pH 7.4) and 10 mg/ml BSA and incubated on ice for 2-4 h in the same medium (250 μl) containing 125 Ilabelled CXCL8 (0.1-1 nM) and GP mutants at concentrations from 0 to 1 μM. The reaction was stopped with 1 ml of icecold PBS containing 10 mg/ml BSA, and cells were washed three times, solubilized with 200 μl of RIPA buffer and dried under vacuum. Bound radioactivity was then measured in a γ -counter and K i values was calculated as described previously [16] . Nonspecific-bound radioactivity was determined in the presence of 500 nM unlabelled WT CXCL8. Binding affinities are from at least two independent experiments, and each experiment was performed at least two times.
Cell culture
CXCR1 and CXCR2 stably transfected RBL-2H3 cells were maintained as monolayer cultures as described previously [17] . Briefly, RBL-2H3 cells (1×10 7 cells) were transfected by electroporation with 20 μg of pcDNA3 containing the receptor cDNAs. Geneticin-resistant cells were selected by FACS analysis and cloned into single cells. Cells were then maintained in DMEM supplemented with 15 % FBS, 2 mM glutamine, 100 units/ml penicillin and 100 mg/ml streptomycin (Gibco, Life Science Technologies).
Intracellular Ca
2 + mobilization CXCR1-and CXCR2-transfected RBL-2H3 cells (5×10 6 ) were washed with Hepes-buffered saline and loaded with 1 μM Indo-I/AM (acetoxymethyl ester) in the presence of 1 μM pluronic acid for 30 min at room temperature (23
• C). The cells were then washed and resuspended in 1.5 ml of Siriganian buffer, and the intracellular Ca 2 + mobilization activity of the GP mutants was measured as described previously [18] . Curve fitting and EC 50 values were determined by non-linear regression analysis of the dose-response curves generated using Prism 5 (GraphPad Software).
ERK (extracellular-signal-regulated kinase) phosphorylation
CXCR1-and CXCR2-transfected RBL-2H3 cells (5×10 7 cells/ml) were stimulated with GP mutants (10 nM) for 1 and 5 min, and lysed with an equal volume of RIPA buffer supplemented with proteinase and phosphatase inhibitors. The sonicated cell lysates were electrophoresed at 150 V for 1 h using SDS/PAGE (12 % gel), transferred on to a PVDF membrane at 100 V for 1 h, and blocked in 5 % non-fat dried skimmed milk in TBST [10 mM Tris (pH 8.0) and 150 mM NaCl containing 0.05 % Tween 20] for 1 h at room temperature. Membranes were immunoblotted with primary antibody overnight and then treated with secondary antibody for 1 h. The protein bands were detected using substrates from the Supersignal West Femto kit (Thermo Scientific) and imaged using the ChemiDoc XRS system (BioRad Laboratories). The rabbit anti-phospho-ERK (Thr 202 /Tyr 204 ) and anti-(p44/p42 total ERK) antibodies were from Cell Signaling Technology, and the secondary goat anti-rabbit IgG antibody was from Santa Cruz Biotechnology.
Peritoneal neutrophil recruitment
Female BALB/c mice (8-10 weeks old) were purchased from Harlan and housed under pathogen-free conditions in the animal research facility, in accordance with the National Institutes of Health and University guidelines for animal care. Under light anaesthesia, mice were inoculated intraperitoneally with 0.25 or 10 μg of GP mutants (full-length 1-72 version) in D-PBS (Dulbecco's PBS). At 6 h post-inoculation, mice were killed and peritoneal neutrophil levels were determined as described previously [19] . The peritoneal cavity was flushed with 1.5 ml of ice-cold HBSS (Hanks balanced salt solution) buffer to collect the migrated neutrophils. Cytospin slides were prepared by centrifuging 100 μl of peritoneal fluid for 5 min at 72 g in a cytocentrifuge (Shandon, Thermo Electron). Slides were then fixed and stained with Wright-Giemsa stain, and 200 cells were counted to determine the percentage of neutrophils. For total leucocyte determination, samples were diluted with Turk blood diluting fluid (Ricca Chemicals), and the total cells were counted using a haemocytometer.
NMR spectroscopy
NMR spectra were acquired at 30
• C on a Varian Unity Plus 600 spectrometer equipped with field gradient accessories. The protein concentrations were ∼0.1 mM in 50 mM sodium phosphate buffer (pH 6.0) containing 1 mM sodium azide, 1 mM DSS (sodium 2,2-dimethyl-2-silapentane sulfonate) and 10 % (v/v) 2 H 2 O. All spectra were processed and analysed as described previously [20] .
Binding of unlabelled CXCR1 N-terminal domain peptide to 15 N-labelled P32G and G31V mutants was characterized using 2D ( 1 H, 15 N)-HSQC (heteronuclear single-quantum coherence) NMR chemical-shift changes. The final peptide/protein molar ratio for the P32G and G31V mutants was 5.2 and 5.8 respectively. Apparent binding constants were determined by fitting the binding-induced chemical shift changes as a function of the peptide/protein molar ratios as described previously [20] .
MD simulations
The CXCL8-(1-66) truncated monomer molecular model was generated using the CXCL8 monomer structure (PDB code 1IKM) [20] . The GP variants were generated by mutating Gly 31 to alanine or valine, and Pro 32 to glycine or alanine. The structures were subjected to multiple cycles of constrained and free-energy minimizations using the AMBER 12 suite to remove steric hindrance introduced by the mutations [21, 22] . The energyminimized structures were subjected to an equilibration protocol in explicit solvent as described previously [22] . MD runs (200 ns) were carried out using the PMEMD (particle mesh Ewald MD) module on the Lonestar Dell Linux Cluster at the TACC (Texas Advanced Computing Center, University of Texas, Austin, TX, U.S.A.). Analysis of the trajectory was carried out using the Ambertools12 and the VMD molecular visualization software [21, 23] .
RESULTS
Cell-based functional assays
We characterized the activity of G31A, G31V, P32G and P32A mutants by measuring binding affinity, Ca 2 + release and ERK phosphorylation using RBL-2H3 cells stably transfected with CXCR1 or CXCR2 receptors (Table 1 and Figure 2 ). All of the mutants bound CXCR2 with high affinity (Table 1) . Although G31V and P32A bound CXCR1 with high affinity, binding of P32G and G31A could not be detected, suggesting that their binding is significantly impaired. The higher affinity of the G31V mutant compared with the WT for both receptors is particularly interesting and unprecedented.
We measured EC 50 values for Ca 2 + release activity of all of the mutants for both CXCR1 and CXCR2 receptors (Table 1 and Figure 2A ). The individual mutants showed a range of activity from WT-like to being inactive. Whereas P32A and G31V were 4-12-fold less active, P32G and G31A were essentially inactive for both of the receptors (Table 1) . We characterized ERK1/2 phosphorylation activity of the mutants at 10 nM at 1 and 5 min time points ( Figure 2B ). In general, the mutants were less active, but there were differences among the mutants as a function of receptor subtype and differences as a function of time point, which suggest differences in phosphorylation kinetics. For CXCR2, all of the mutants were essentially inactive at the 1 min time point and only the WT was active. However, at the 5 min time point, P32A and G31V were active. For CXCR1, all mutants showed impaired activity, except P32A, which was as active as the WT at the 5 min time point.
Neutrophil recruitment in a mouse model
Neutrophil recruitment in animal models best captures the importance of all of the signalling pathways, and is the most stringent to understand and characterize the consequence of the different mutations for function. We measured neutrophil recruitment activity of the GP mutants at 0.25 and 10 μg doses in a mouse peritoneum model ( Figure 3) . Interestingly, the G31V mutant was more active than the WT at the 10 μg dose (P < 0.01) and is as active as the WT at the 0.25 μg dose. All other mutants were significantly less active than the WT (P < 0.01); only G31V and P32A were active at the lower dose, and P32A showed slightly better recruitment than the G31A and P32G mutants at the higher dose. In vivo recruitment is dependent on CXCL8 binding to CXCR2 on neutrophils and GAGs (glycosaminoglycans) on endothelial cells. WT CXCL8 exists reversibly as both monomers and dimers, and we have shown that the recruitment at the 0.25 μg dose is predominantly from a monomer, and from both the monomer and dimer forms at the 10 μg dose [19] . As the GP motif plays no role in GAG binding, reduced recruitment must be due to reduced receptor function. The high activity of G31V is particularly intriguing, as it also binds with higher affinity than the WT to its receptors. As the mutants were bacterially expressed, it could be argued that the higher activity of the G31V mutant is due to spurious contaminants such as LPS (lipopolysaccharide). We rule this out as the P32G mutant is essentially inactive, and the R6K and CC-CXCL8 mutants purified using the same protocol were also inactive [19, 24] . It is possible that the higher activity is due to differences between the human and mouse CXCR2 receptor and/or that the conformational ensemble of G31V enables receptor activation (see Discussion). Independent of the actual mechanism of binding, these data convincingly show that the glycine residue of the GP motif cannot be involved in direct binding.
Structural characterization of GP mutants
Proline and glycine residues are frequently observed in turn regions that link secondary structural elements in proteins [25, 26] .
Figure 3 Neutrophil recruitment in a mouse peritoneum model
Data are means + − S.E.M., and represent four to five mice/group. At the 10 μg dose, the higher recruitment of G31V and lower recruitment of other mutants were significant compared with the WT ( * * * P < 0.01). At the 0.25 μg dose, all mutants, except G31V, were less active compared with the WT ( * * * P < 0.01). One-way ANOVA with Tukey's post-hoc test was used to determine statistical significance.
Proline is unique due to its cyclic pyrrolidine ring side chain that restricts its φ/ψ conformational space in the Ramachandran plot, and also because it cannot form a backbone hydrogen bond as it lacks the amide proton. Glycine is also unique as it is not conformationally constrained due to lack of a side chain and can occupy regions of the φ/ψ space that are inaccessible to other residues. In the WT CXCL8, Gly 31 , Pro 32 , His 33 and Cys 34 form a tight type I β-turn, and the backbone of Gly 31 and Cys 34 are hydrogen-bonded to each other ( Figure 1B ) [27] [28] [29] .
The structural consequence of mutations in the GP motif was characterized for the P32G and G31V mutants by solution NMR spectroscopy. We chose these mutants for the reason that G31V was the most active and P32G the least active. We produced the mutants on the CXCL8-(1-66) monomer background, and so will refer to the CXCL8-(1-66) monomer as the WT when discussing NMR data. Chemical shifts are exquisitely sensitive to secondary and tertiary structures, and therefore identical chemical shifts between the mutant and WT indicate identical structures [30] . Chemical shifts indicate that both mutants adopt a CXCL8-like fold, but also showed local structural changes of the 30s-loop ( Figure 4A and Supplementary Figure S1A at http://www.biochemj.org/bj/456/bj4560241add.htm). Plots of the backbone amide proton chemical shifts of the P32G mutant compared with the WT showed that most residues fell on the diagonal, indicating essentially a similar global folded structure ( Figures 4B and 4C) . Cys 34 has a characteristic up-field chemical shift in the WT, and the chemical shifts of Gly 31 and Cys 34 in the mutant are similar to those in the WT, indicating that the β-turn structure is conserved. Chemical shifts of the G31V mutant showed larger changes in the 30s-loop residues, indicating local structural perturbation around the site of mutation (Supplementary Figure S1) . The observation that G31V is more active than P32G indicates that structural changes as a consequence of the mutation do not negatively influence function. A previous NMR study of the G31P mutant has also shown that its structure is like the WT [31] .
Structural characterization of CXCL8 receptor Site-I interaction
The structural basis of Site-I interactions can be characterized outside the context of the intact receptor by studying binding to receptor N-domain peptides using NMR spectroscopy [20, 32] . We have previously shown that binding to the CXCR1 N-domain induces significant chemical-shift perturbation of CXCL8 N-loop, β 3 -strand and C-terminal helix residues, and that N-loop residues are involved in direct binding and that the β 3 -strand and Cterminal helix residues indirectly influence the binding of N-loop residues via coupling interactions [20] .
Chemical-shift perturbation profiles of the P32G mutant on binding to the CXCR1 N-domain peptide were essentially identical with that observed for the WT ( Figure 5 ). A number of residues broaden out during the course of binding and reappear at higher receptor concentrations, similar to what is observed for the WT, indicating that the binding is in the fast to intermediate exchange regime in the NMR time scale ( Figure 5A ). Chemical shifts of the GP motif are not perturbed either in the WT or the mutant, indicating that these residues are not involved in direct binding to the receptor N-domain ( Figures 5C and 5D ). Not surprisingly, we also observed that the chemical-shift perturbation profile of the G31V mutant is similar to that of WT (Supplementary Figures S2A and S2B at http://www.biochemj.org/bj/456/bj4560241add.htm).
The binding affinity of the P32G mutant for the receptor Ndomain (K d = 11 + − 1 μM) is identical with the WT (Figure 5B ), indicating that Pro 32 does not participate or influence Site-I interactions. The binding affinity of the G31V mutant for the receptor N-domain (K d = 50 + − 10 μM) is approximately ∼4-fold weaker compared with the WT, but it actually binds the intact receptor with higher affinity, indicating that weaker binding to Site-I must be compensated by positive coupling interactions to Site-II, and most importantly that Gly 31 is also not critical for highaffinity receptor binding (Supplementary Figure S2C) . Therefore large variation in the activity of the mutants cannot be attributed to Site-I interactions, and indicate that the GP motif influences the receptor-activation step of the N-terminal residues at Site-II.
Conformational dynamics of GP mutants
NMR and X-ray structures can be viewed as an average structure or a snapshot of a conformational ensemble in dynamic equilibrium, and so cannot provide the detailed spatial and temporal description of the relative motions between structural modules. Computational MD simulation studies can provide this critical knowledge. In order to characterize how the GP motif influences structure and mediates cross-talk between N-terminal and N-loop residues, we carried out 200 ns MD simulations on the CXCL8-(1-66) monomer (WT), and each of the four GP mutants (P32G, P32A, G31V and G31A) in the same monomer background, using the AMBER 12 suite [21] . at http://www.biochemj.org/bj/456/bj4560241add.htm). Analysis showed that the conformer GG C1 , observed over the course of the simulation, retained type I β-turn architecture observed in the WT (Figures 6A and Supplementary Figure S4 at http://www.biochemj.org/bj/456/bj4560241add.htm). Conformer GG C2 , which has the longest lifetime during the entire simulation, results from a complete structural rearrangement of the 30s-loop, arising from concerted conformational change in backbone and side chains of Glu 29 Figure S3) . This results in a transition from a type I to type II' β-turn conformation [25, 26] . Overlay of the GG C2 conformer with WT showed a large difference in the structure of the 30s-loop, including a change in the conformation of the Cys 7 -Cys 34 disulfide bridge ( Figure 6B Figure 6C ).
P32A mutant
In stark contrast with the P32G mutant, the 30s-loop β-turn retains the native WT-like type I conformation in the P32A mutant ( Figure 6D ), and no additional distinct conformers were observed. The less bulky alanine side chain compared with the pyrrolidine ring results in increased flexibility/dynamics of the 30s-loop, which is evident from backbone φ/ψ angle fluctuations (results not shown). The relative orientation and modular motions of the 30s-loop in concert with the N-loop and N-terminus are similar to those observed for the WT. • /150
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• , which nevertheless does not introduce any perturbation in the β 1 -strand. The overlay of structures at regular intervals over the course of the trajectory show that the relative orientation of the 30s-loop with the N-loop and N-terminal residues are fairly similar to that seen in WT ( Figure 7A ).
G31A mutant
Analysis of the MD trajectory showed that there was increased flexibility in the 30s-loop compared with G31V. We observed two distinct conformers, AP C1 (∼80 %) and AP C2 (∼20 %), for the 30s-loop. The major AP C1 conformer was similar to that observed for G31V. The AP C2 conformer showed a concerted rearrangement in the 30s-loop (Ser 30 , Gly 31 , Pro 32 and His 33 ) resulting in a type II β-turn and non-native 30s-loop conformer and altered orientation of the 30s-loop, N-terminus and N-loop ( Figure 7B) .
The MD studies of the GP mutants have provided crucial insights as to why the GP motif is stringent and essential for optimal cross-talk and receptor activation. In particular, the non-native conformers observed for P32G and G31A, and the altered dynamics and the structural reorientation of the 30s-loop, N-terminal and N-loop domains could not have been predicted from the MD studies of the WT alone.
DISCUSSION
Protein ligands, such as chemokines, are unusual agonists for class A GPCRs, as conventional agonists tend to be small molecules, such as biogenic amines, peptides and those related to taste and smell [33] . The small molecule agonists activate the receptor by binding to the extracellular/transmembrane residues (Site-II). The larger size of the chemokines must confer functional advantages that cannot be achieved by small molecule agonists, and at the same time, chemokines must have evolved distinct molecular mechanisms that exploit their large size and multimodular structure for receptor activation. Indeed, chemokines also bind to the receptor N-terminal domain (Site-I) in addition to Site-II. However, even this two-site mechanism fails to describe the large differences in affinity, potency, receptor selectivity and functional responses for any given chemokine and among different chemokines. Clearly, other structural components of the protein must regulate the binding interactions of the N-loop and Nterminal residues.
Our structural, functional and computational characterization of CXCL8 GP mutants has now provided compelling evidence that the GP motif couples Site-I and Site-II interactions. The observation that the G31V mutant has higher affinity and could be more active in vivo than the WT indicates that Gly 31 does not make direct receptor-binding interactions, as the steric bulk of the isopropyl group [-CH-(CH 3 ) 2 ] of the valine side chain will interfere in the binding process. Intriguingly, an alanine mutation results in lower activity, although its side chain methyl group (-CH 3 ) has smaller steric bulk compared with valine. Receptor affinities of the Pro 32 mutants were dependent on the nature of the mutation and receptor subtype. The binding of P32A to both receptors, and the binding of P32G to CXCR2, were similar to that of WT, but P32G showed impaired binding to CXCR1. Not surprisingly, P32A showed overall higher activity than the P32G mutant. The large differences among the P32 mutants also indicate that the side chain of Pro 32 makes no direct receptor interactions. NMR studies show that the local structural changes as a consequence of mutation cannot be correlated with functional changes. On the other hand, MD simulations indicate that the GP mutants populate non-native conformations, which can dominate and result in suboptimal cross-talk between modules that mediate the receptor activation process. Other mutational studies have also shown that the GP mutants bind like the WT [34, 35] . These data together indicate that the GP motif does not make direct receptor contacts and must indirectly influence the receptor activation process.
On the basis of our present and previous structure-function studies, we propose that the 'conformational-selection' model best describes how CXCL8 and all chemokines bind and activate their receptors [11, 12, 36] . According to this model, all protein conformations pre-exist in dynamic equilibrium, and on binding to their partners, the conformational ensemble undergoes a population shift, thereby redistributing the conformational substates [37] [38] [39] [40] [41] . The existence of this phenomenon and its importance in functional scenarios has been well established through X-ray, NMR, MD, single-molecule fluorescence and kinetics studies [42] [43] [44] [45] . Also, several studies on protein dynamics has led to the proposal that independent protein segments, such as the 30s-loop whose dynamics are distinctly different from the rest of the protein scaffold, can govern conformational transitions and dictate specificity for protein-protein recognition and activation of signalling cascades [46, 47] .
Previous structure-function studies on the conserved Nterminal residues and disulfides have also provided compelling evidence on the importance of conformational dynamics and function. CXCL8 structures reveal that the 30s-loop and the N-terminal residues are linked via the Cys 7 -Cys 34 disulfide bond and form a contiguous surface ( Figure 1B ). Cys 7 -Cys 34 disulfide is essential for function, as deleting or modifying the disulfide by introducing non-natural cysteine analogues results in substantial loss of activity [48, 49] . The CXC motif in CXCL8 is also critical, as deleting the intervening Gln 8 residue results in significant loss of function [24] . Structures of Cys 7 -Cys 34 disulfide-modified mutants are indistinguishable from the WT and the disulfides are buried, indicating that the disulfides and CXC motif cannot be involved in direct receptor interactions and that they indirectly influence the receptor activation process [48] . Structures and characterization of dynamics from NMR relaxation measurements also reveal that the N-terminal residues are unstructured and highly mobile, and the N-loop and 30s-loop residues and the disulfides are structured, but conformationally flexible [27] [28] [29] [50] [51] [52] . The structure of CXCR1 was recently solved by solid-state NMR spectroscopy, but the N-terminal domain in the structure could not be defined, indicating that it is dynamic and conformationally flexible [53] . However, binding studies of CXCL8 to the isolated CXCR1 N-domains have shown that the N-domain adopts an extended and definite structure in the bound form [54] . We propose that the N-terminus, N-loop and 30s-loop, and the disulfide residues, exist as a conformational ensemble. Chemokine receptors also exist as a conformational ensemble, and it has been proposed that the ligands selectively bind the active conformer, and/or that binding results in a redistribution of the ensemble [55, 56] . In essence, the receptor activation involves a series of co-ordinated conditional and discrete binding steps involving both partners, a process termed 'interdependent protein dance' [57, 58] . Therefore each binding step generates a distinctly different conformational state dictated by the conformational ensemble equilibrium, and a mutation could result in a WT-like ensemble with no effect on affinity or activity, a functionally impaired ensemble that has reduced binding affinity and/or activity for some (but not all) signalling pathways, or a functionally enhanced ensemble that has increased binding affinity and/or activity. The proposed model is robust and in excellent agreement with the generalized concept of 'conformational selection and population shift', and can account for the large range in the observed changes both in affinity and activity [11, 12] . For instance, the new model can explain the large differences in affinity and activity of the P32G and G31V and of the N-terminal ELR and disulfide mutants, and the antagonist activity of the N-terminal (such as R6K) and GP (such as G31P) mutants [31, 59] . Furthermore, our proposed model can also explain how CXCL7/NAP-2 can activate neutrophils despite having a threonine substitution for proline ( Figure 1A) ; its conformational ensemble, like in the G31V, enables receptor activation at Site-II [60] .
Temporally, the very first step involves binding interactions between chemokine N-loop and receptor N-domain residues at Site-I, and the very last step involves receptor activation by the N-terminal residues at Site-II. The initial binding must induce structural/dynamic changes in the ligand that facilitate activation by the ELR residues. Disulfide bonds, especially the Cys 7 -Cys 34 link, clearly play an important role for activation at Site-II [24, 48] . We propose that the penultimate step involves the conformational switching by the GP motif of the N-terminal ELR residues for receptor activation, resulting in downstream signalling events. We further propose that a conformational ensemble model best describes activation profiles and functional responses for all chemokine/receptor pairs. A network of mosaic interactions in the ensemble provides superb control in mediating the multistep processes involved in multiple receptor signalling pathways, and this shared property among chemokines enables diverse ligand and receptor selectivity and different signalling activities. Interestingly, a tripeptide PGP (proline-glycine-proline) recruits neutrophils, and it has been proposed that it does so by activating CXCR1/CXCR2 receptors [61] . These authors propose that the PGP tripeptide binds CXCR1/CXCR2 receptors by mimicking the 30s-loop GP residues on the basis that the peptide adopts the conformation of the GP motif observed in CXCL8 structures, and a previous study that showed mutating GP to PG results in a significant loss of activity [7, 61] . The PGP peptide shows much lower potency (>1000-fold) and the authors propose that this is because the peptide binds only part of the receptor. High binding affinities of the GP mutants, especially of the G31V mutant, cannot account for activity of the PGP peptides as due to mimicking the structure and function of the GP motif. Our conclusion that the GP motif does not make direct receptor interactions, but modulates the conformational ensemble, indicates that any semblance of the tripeptide to the GP motif structure is incidental. This provides compelling evidence that even if PGP does bind CXCR1/CXCR2 receptors for neutrophil recruitment, its mechanism of action is completely unrelated to the CXCL8 mode of action [62] . 
